Transnetyx
Megan Grotts is an experienced sales professional with a strong background in pharmaceuticals and biotechnology. Currently serving as a Senior Key Account Specialist at Transnetyx since February 2018, Megan has contributed to enhancing research methodologies via Automated Genotyping and other advanced technologies. Prior to Transnetyx, experience included roles at Sanofi from February 2006 to February 2018, where responsibilities encompassed market growth for various pharmaceutical brands to a diverse range of medical specialists. Megan also held the position of Account Manager at Abbott from November 2004 to February 2006, focusing on nutrition products and maintaining significant market shares. Megan holds a B.S. in Sales Management from Purdue University, obtained between 2001 and 2004.
This person is not in any offices
Transnetyx
1 followers
Transnetyx is an automated genotyping company dedicated to serving research and saving time by removing redundant, yet necessary, tests conducted in genetic research. By optimizing resources, Transnetyx has paved the way for research to advance and deeper understandings to emerge. Founded in 2000 and headquartered in Memphis, Tenn., Transnetyx launched the world’s first fully-automated genotyping system for detecting transgenic, knockout, knock-in, SNP and CRISPR mutations in animal research models. Transnetyx has genotyped more than 25 million samples worldwide in 24 or 72 hours with 99.97 percent accuracy. It has built a genetic database of more than 20,000 assays and is the trusted genotyping resource for thousands of researchers in universities, hospitals and bioscience companies around the world. The mission of Transnetyx, then and now, is to help scientists accelerate research with fast, easy and accurate genotyping services. For more information, visit transnetyx.com. For current job openings, visit transnetyx.com/careers.